| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $2.55 | $2.05 | $2.46 | $2.41 | $1.42 | $1.82 |
| EPS (Diluted) | $2.52 | $2.02 | $2.44 | $2.39 | $1.41 | $1.81 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Total Assets | $3.6B | $3.5B | $3.4B | $3.1B | $1.9B | $1.6B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.1B | $0.2B | $0.4B | $0.2B | $0.3B |
| Total Liabilities | $3.2B | $3.1B | $3.1B | $2.8B | $1.7B | $1.4B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| Investing Cash Flow | $0.0B | $-0.1B | $-0.7B | $-0.9B | $-0.5B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.0B | $-0.0B | $0.3B | $1.2B | $0.2B | $0.1B |